Literature DB >> 25789852

Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.

Nawal Bendris1, Bénédicte Lemmers, Jean Marie Blanchard.   

Abstract

While targeting experiments carried out on the genes encoding many cell cycle regulators have challenged our views of cell cycle control, they also suggest that redundancy might not be the only explanation for the observed perplexing phenotypes. Indeed, several observations hint at functions of cyclins and CDK inhibitors that cannot be accounted for by their sole role as kinase regulators. They are found involved in many cellular transactions, depending or not on CDKs that are not directly linked to cell cycle control, but participating to general mechanisms such as transcription, DNA repair or cytoskeleton dynamics. In this review we discuss the roles that these alternative functions might have in cancer cell proliferation and migration that sometime even challenge their definition as proliferation markers.

Entities:  

Keywords:  EMT; Rho GTPases; cytoskeleton; invasion; mitosis; transcription

Mesh:

Substances:

Year:  2015        PMID: 25789852      PMCID: PMC4614797          DOI: 10.1080/15384101.2014.998085

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  141 in total

1.  Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.

Authors:  M Sánchez-Beato; F I Camacho; J C Martínez-Montero; A I Sáez; R Villuendas; L Sánchez-Verde; J F García; M A Piris
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

Review 2.  Rho and Rac take center stage.

Authors:  Keith Burridge; Krister Wennerberg
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells.

Authors:  Zhijiu Zhong; Wen-Shuz Yeow; Chunhua Zou; Richard Wassell; Chenguang Wang; Richard G Pestell; Judy N Quong; Andrew A Quong
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

4.  p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.

Authors:  Gustavo Baldassarre; Barbara Belletti; Milena S Nicoloso; Monica Schiappacassi; Andrea Vecchione; Paola Spessotto; Andrea Morrione; Vincenzo Canzonieri; Alfonso Colombatti
Journal:  Cancer Cell       Date:  2005-01       Impact factor: 31.743

5.  Control of sleep by cyclin A and its regulator.

Authors:  Dragana Rogulja; Michael W Young
Journal:  Science       Date:  2012-03-30       Impact factor: 47.728

6.  RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.

Authors:  Anne Hakem; Otto Sanchez-Sweatman; Annick You-Ten; Gordon Duncan; Andrew Wakeham; Rama Khokha; Tak W Mak
Journal:  Genes Dev       Date:  2005-08-17       Impact factor: 11.361

7.  Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.

Authors:  Chenguang Wang; Nagarajan Pattabiraman; Jian Nian Zhou; Maofu Fu; Toshiyuki Sakamaki; Chris Albanese; Zhiping Li; Kongming Wu; James Hulit; Peter Neumeister; Phyllis M Novikoff; Michael Brownlee; Philipp E Scherer; Joan G Jones; Kathleen D Whitney; Lawrence A Donehower; Emily L Harris; Thomas Rohan; David C Johns; Richard G Pestell
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

8.  Cyclin A2, a novel regulator of EMT.

Authors:  Nawal Bendris; Caroline T Cheung; Hon Sing Leong; John D Lewis; Ann F Chambers; Jean Marie Blanchard; Bénédicte Lemmers
Journal:  Cell Mol Life Sci       Date:  2014-05-31       Impact factor: 9.261

9.  The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics.

Authors:  P Vlachos; B Joseph
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

10.  Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements.

Authors:  Nawal Bendris; Bénédicte Lemmers; Jean-Marie Blanchard; Nikola Arsic
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

View more
  65 in total

1.  Circ_0000745 strengthens the expression of CCND1 by functioning as miR-488 sponge and interacting with HuR binding protein to facilitate the development of oral squamous cell carcinoma.

Authors:  Kuangzheng Li; Xiaosheng Fan; Ziyi Yan; Jia Zhan; Fangyun Cao; Yixia Jiang
Journal:  Cancer Cell Int       Date:  2021-05-21       Impact factor: 5.722

2.  Role of Spata34 in cell proliferation and its expression pattern in postnatal development of rat testis.

Authors:  Dongsong Nie; Hui Li; Yu Liu; Zhiyong Liao
Journal:  Mol Biol Rep       Date:  2018-10-19       Impact factor: 2.316

3.  Fibroblast growth factor 9 (FGF9) regulation of cyclin D1 and cyclin-dependent kinase-4 in ovarian granulosa and theca cells of cattle.

Authors:  M L Totty; B C Morrell; L J Spicer
Journal:  Mol Cell Endocrinol       Date:  2016-11-03       Impact factor: 4.102

Review 4.  Cyclin A2: At the crossroads of cell cycle and cell invasion.

Authors:  Abdelhalim Loukil; Caroline T Cheung; Nawal Bendris; Bénédicte Lemmers; Marion Peter; Jean Marie Blanchard
Journal:  World J Biol Chem       Date:  2015-11-26

Review 5.  Recent Advances of Cell-Cycle Inhibitor Therapies for Pediatric Cancer.

Authors:  Christopher C Mills; E A Kolb; Valerie B Sampson
Journal:  Cancer Res       Date:  2017-11-02       Impact factor: 12.701

6.  Jungermannenone A and B induce ROS- and cell cycle-dependent apoptosis in prostate cancer cells in vitro.

Authors:  Yan-Xia Guo; Zhao-Min Lin; Mei-Juan Wang; Yi-Wen Dong; Huan-Min Niu; Charles Yf Young; Hong-Xiang Lou; Hui-Qing Yuan
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

Review 7.  Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases.

Authors:  Per Hydbring; Marcos Malumbres; Piotr Sicinski
Journal:  Nat Rev Mol Cell Biol       Date:  2016-04-01       Impact factor: 94.444

8.  DAAM1 and DAAM2 are co-required for myocardial maturation and sarcomere assembly.

Authors:  Rieko Ajima; Joseph A Bisson; Jay-Christian Helt; Masa-Aki Nakaya; Raymond Habas; Lino Tessarollo; Xi He; Edward E Morrisey; Terry P Yamaguchi; Ethan David Cohen
Journal:  Dev Biol       Date:  2015-10-23       Impact factor: 3.582

9.  Naringenin inhibits transforming growth factor-β1-induced cardiac fibroblast proliferation and collagen synthesis via G0/G1 arrest.

Authors:  Mingxin Liu; Xiping Xu; Jianhua Zhao; Yanhong Tang
Journal:  Exp Ther Med       Date:  2017-09-05       Impact factor: 2.447

Review 10.  The double dealing of cyclin D1.

Authors:  Guergana Tchakarska; Brigitte Sola
Journal:  Cell Cycle       Date:  2019-12-29       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.